- Higher Education Institution/University
I was born in Germany and attended medical school in Dublin, Ireland. I completed a pediatric residency in Miami, an Infectious Disease Fellowship at UCLA and a PhD in epidemiology from the London School of Tropical Medicine and Hygiene. Between 1995 and 2000 I worked in The Gambia on the first evaluations of ACTs in subSaharan Africa. From 2000 through 2010 I was employed by the International Vaccine Institute in Seoul, Korea where I managed large vaccine evaluation projects including an oral cholera vaccine in Mozambique and Zanzibar. From 2006 I coordinated a trial of the malaria vaccine candidate RTS,S/ASO1 in Tanzania. From 2003 I collaborated with the Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand on a large multicentre trial (AQUAMAT) to compare the efficacy of parenteral artesunate with parenteral quinine for severe malaria. From 2010 I coordinated the APMEN vivax working group in Darwin, Australia. From 2014 I worked on the evaluation of mass drug administrations to interrupt the transmission of malaria at the Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand. My current main interests are housing innovations to control and eliminate a range of diseasesincluding malaria, respiratory tract infections and enteric diseases. Other interests include the the treatment of vivax malaria and the inclusion of vaccines in the targetd elimination of malaria.
The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases. Improving buildings has been one of the oldest and most neglected interventions in the fight against malaria.